Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy von Kjeldsen, SAS, Gluud, LL, Werge, MP, Pedersen, JS, Bendtsen, F, Alexiadou, K, Tan, T, Torekov, SS, Iepsen, EW, Jensen, NJ, Richter, MM, Goetze, JP, Rungby, J, Hartmann, B, Holst, JJ, Holst, B, Holt, J, Gustafsson, F, Madsbad, S, Svane, MS, Bojsen-Møller, KN, Wewer Albrechtsen, NJ

Volltext